155 related articles for article (PubMed ID: 31773687)
1. High expression of SHMT2 is correlated with tumor progression and predicts poor prognosis in gastrointestinal tumors.
Liu Y; Yin C; Deng MM; Wang Q; He XQ; Li MT; Li CP; Wu H
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(21):9379-9392. PubMed ID: 31773687
[TBL] [Abstract][Full Text] [Related]
2. High Expression of Serine Hydroxymethyltransferase 2 Indicates Poor Prognosis of Gastric Cancer Patients.
Shi H; Fang X; Li Y; Zhang Y
Med Sci Monit; 2019 Oct; 25():7430-7438. PubMed ID: 31581160
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and therapeutic value of mitochondrial serine hydroxyl-methyltransferase 2 as a breast cancer biomarker.
Zhang L; Chen Z; Xue D; Zhang Q; Liu X; Luh F; Hong L; Zhang H; Pan F; Liu Y; Chu P; Zheng S; Lou G; Yen Y
Oncol Rep; 2016 Nov; 36(5):2489-2500. PubMed ID: 27666119
[TBL] [Abstract][Full Text] [Related]
4. Increased Expression of Serine Hydroxymethyltransferase 2 (SHMT2) is a Negative Prognostic Marker in Patients with Hepatocellular Carcinoma and is Associated with Proliferation of HepG2 Cells.
Ji L; Tang Y; Pang X; Zhang Y
Med Sci Monit; 2019 Aug; 25():5823-5832. PubMed ID: 31379360
[TBL] [Abstract][Full Text] [Related]
5. Proteomic profiling of breast cancer metabolism identifies SHMT2 and ASCT2 as prognostic factors.
Bernhardt S; Bayerlová M; Vetter M; Wachter A; Mitra D; Hanf V; Lantzsch T; Uleer C; Peschel S; John J; Buchmann J; Weigert E; Bürrig KF; Thomssen C; Korf U; Beissbarth T; Wiemann S; Kantelhardt EJ
Breast Cancer Res; 2017 Oct; 19(1):112. PubMed ID: 29020998
[TBL] [Abstract][Full Text] [Related]
6. SHMT2 Drives the Progression of Colorectal Cancer by Regulating UHRF1 Expression.
Cui X; Cui Y; Du T; Jiang X; Song C; Zhang S; Ma C; Liu Y; Ni Q; Gao Y; Wang G
Can J Gastroenterol Hepatol; 2022; 2022():3758697. PubMed ID: 35211429
[TBL] [Abstract][Full Text] [Related]
7. Mitochondrial serine hydroxymethyltransferase 2 is a potential diagnostic and prognostic biomarker for human glioma.
Wang B; Wang W; Zhu Z; Zhang X; Tang F; Wang D; Liu X; Yan X; Zhuang H
Clin Neurol Neurosurg; 2017 Mar; 154():28-33. PubMed ID: 28107674
[TBL] [Abstract][Full Text] [Related]
8. The expression and clinical significance of serine hydroxymethyltransferase2 in gastric cancer.
Shan Y; Liu D; Li Y; Wu C; Ye Y
PeerJ; 2024; 12():e16594. PubMed ID: 38188143
[TBL] [Abstract][Full Text] [Related]
9. Cancer proteome and metabolite changes linked to SHMT2.
Tong J; Krieger JR; Taylor P; Bagshaw R; Kang J; Jeedigunta S; Wybenga-Groot LE; Zhang W; Badr H; Mirhadi S; Pham NA; Coyaud É; Yu M; Li M; Cabanero M; Raught B; Maynes JT; Hawkins C; Tsao MS; Moran MF
PLoS One; 2020; 15(9):e0237981. PubMed ID: 32903271
[TBL] [Abstract][Full Text] [Related]
10. miR-615-5p prevents proliferation and migration through negatively regulating serine hydromethyltransferase 2 (SHMT2) in hepatocellular carcinoma.
Wu X; Deng L; Tang D; Ying G; Yao X; Liu F; Liang G
Tumour Biol; 2016 May; 37(5):6813-21. PubMed ID: 26662310
[TBL] [Abstract][Full Text] [Related]
11. SHMT2 Overexpression Predicts Poor Prognosis in Intrahepatic Cholangiocarcinoma.
Ning S; Ma S; Saleh AQ; Guo L; Zhao Z; Chen Y
Gastroenterol Res Pract; 2018; 2018():4369253. PubMed ID: 30228815
[TBL] [Abstract][Full Text] [Related]
12. Downregulating serine hydroxymethyltransferase 2 (SHMT2) suppresses tumorigenesis in human hepatocellular carcinoma.
Woo CC; Chen WC; Teo XQ; Radda GK; Lee PT
Oncotarget; 2016 Aug; 7(33):53005-53017. PubMed ID: 27391339
[TBL] [Abstract][Full Text] [Related]
13. SHMT2 Promotes Gastric Cancer Development through Regulation of HIF1α/VEGF/STAT3 Signaling.
Wang W; Wang M; Du T; Hou Z; You S; Zhang S; Ji M; Xue N; Chen X
Int J Mol Sci; 2023 Apr; 24(8):. PubMed ID: 37108312
[TBL] [Abstract][Full Text] [Related]
14. Downregulation of SHMT2 promotes the prostate cancer proliferation and metastasis by inducing epithelial-mesenchymal transition.
Chen L; Liu H; Ji Y; Ma Z; Shen K; Shangguan X; Qian H; Zhao Y; Pan CW; Xue W
Exp Cell Res; 2022 Jun; 415(2):113138. PubMed ID: 35398308
[TBL] [Abstract][Full Text] [Related]
15. Deacetylation of serine hydroxymethyl-transferase 2 by SIRT3 promotes colorectal carcinogenesis.
Wei Z; Song J; Wang G; Cui X; Zheng J; Tang Y; Chen X; Li J; Cui L; Liu CY; Yu W
Nat Commun; 2018 Oct; 9(1):4468. PubMed ID: 30367038
[TBL] [Abstract][Full Text] [Related]
16. Positive correlation between expression level of mitochondrial serine hydroxymethyltransferase and breast cancer grade.
Yin K
Onco Targets Ther; 2015; 8():1069-74. PubMed ID: 25999742
[TBL] [Abstract][Full Text] [Related]
17. Serine catabolism regulates mitochondrial redox control during hypoxia.
Ye J; Fan J; Venneti S; Wan YW; Pawel BR; Zhang J; Finley LW; Lu C; Lindsten T; Cross JR; Qing G; Liu Z; Simon MC; Rabinowitz JD; Thompson CB
Cancer Discov; 2014 Dec; 4(12):1406-17. PubMed ID: 25186948
[TBL] [Abstract][Full Text] [Related]
18. SHMT2 Desuccinylation by SIRT5 Drives Cancer Cell Proliferation.
Yang X; Wang Z; Li X; Liu B; Liu M; Liu L; Chen S; Ren M; Wang Y; Yu M; Wang B; Zou J; Zhu WG; Yin Y; Gu W; Luo J
Cancer Res; 2018 Jan; 78(2):372-386. PubMed ID: 29180469
[TBL] [Abstract][Full Text] [Related]
19. Serine hydroxymethyltransferase 2: a novel target for human cancer therapy.
Xie M; Pei DS
Invest New Drugs; 2021 Dec; 39(6):1671-1681. PubMed ID: 34215932
[TBL] [Abstract][Full Text] [Related]
20. Evaluating the clinical significance of SHMT2 and its co-expressed gene in human kidney cancer.
Wang H; Chong T; Li BY; Chen XS; Zhen WB
Biol Res; 2020 Oct; 53(1):46. PubMed ID: 33066813
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]